Ownership

Kenneth B. Lee Jr - Insider Trading & Ownership

Entity: Individual
Location: 7100 West Credit Avenue, Suite 101, C/O Aralez Pharmaceuticals Inc., Mississauga, Ontario, Canada
Summary: The estimated net worth of Kenneth B. Lee Jr is at least $504K dollars as of June 15, 2023. Kenneth B. Lee Jr is the Director of BIOCRYST PHARMACEUTICALS INC and owns shares of BIOCRYST PHARMACEUTICALS INC (BCRX) stock worth about $417K. Kenneth B. Lee Jr is the Director of EYENOVIA, INC. and owns shares of EYENOVIA, INC. (EYEN) stock worth about $87.8K.
All Insider Reports: All Insider Reports

Ownership of Kenneth B. Lee Jr

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
BCRX	BIOCRYST PHARMACEUTICALS INC	Director	$417K			Jun 13, 2023
EYEN	EYENOVIA, INC.	Director	$87.8K			Jun 16, 2022

Showing 1 to 2 of 2 entries

Insider Transactions Reported by Kenneth B. Lee Jr:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
BCRX	Biocryst Pharmaceuticals Inc	Common Stock	Award	+32.1%	$0	0.00	+16.7K	68.9K	6/13/2023	Direct
BCRX	Biocryst Pharmaceuticals Inc	Automatic Stock Option Grant	Award		$0	0.00	+39.1K	39.1K	6/13/2023	Direct
BCRX	Biocryst Pharmaceuticals Inc	Common Stock	Options Exercise	+40.4%	$25.7K	1.71	+15K	52.1K	1/31/2023	Direct
BCRX	Biocryst Pharmaceuticals Inc	Automatic Stock Option Grant	Options Exercise	-100%	$0	0.00^*	-15K	0	1/31/2023	Direct
EYEN	Eyenovia, Inc.	Common Stock, par value $.0001	Award	+52.5%	$0	0.00	+22.2K	64.5K	6/16/2022	Direct
EYEN	Eyenovia, Inc.	Stock Option (right to buy)	Award		$0	0.00	+30.8K	30.8K	6/16/2022	Direct
BCRX	Biocryst Pharmaceuticals Inc	Common Stock	Award	+53.1%	$0	0.00	+12.9K	37.1K	6/7/2022	Direct
BCRX	Biocryst Pharmaceuticals Inc	Automatic Stock Option Grant	Award		$0	0.00	+30K	30K	6/7/2022	Direct
EYEN	Eyenovia, Inc.	Common Stock, par value $.0001	Purchase	+30.9%	$22K	2.20	+10K	42.3K	5/19/2022	Direct
EYEN	Eyenovia, Inc.	Common Stock, par value $.0001	Award	+27.5%	$0	0.00	+6.96K	32.3K	11/17/2021	Direct
EYEN	Eyenovia, Inc.	Stock Option (right to buy)	Award		$0	0.00	+9.65K	9.65K	11/17/2021	Direct
BCRX	Biocryst Pharmaceuticals Inc	Common Stock	Options Exercise	+98.4%	$48.3K	3.22	+15K	30.3K	9/13/2021	Direct
BCRX	Biocryst Pharmaceuticals Inc	Common Stock	Sale	-19.8%	-$92.1K	15.35	-6K	24.3K	9/13/2021	Direct
BCRX	Biocryst Pharmaceuticals Inc	Automatic Stock Option Grant	Options Exercise	-100%	$0	0.00^*	-15K	0	9/13/2021	Direct
EYEN	Eyenovia, Inc.	Common Stock, par value $.0001	Purchase	+8.56%	$10.8K	5.41	+2K	25.4K	6/15/2021	Direct
EYEN	Eyenovia, Inc.	Common Stock, par value $.0001	Purchase	+9.36%	$10.9K	5.47	+2K	23.4K	6/14/2021	Direct
EYEN	Eyenovia, Inc.	Common Stock, par value $.0001	Purchase	+10.3%	$10.8K	5.38	+2K	21.4K	6/11/2021	Direct
BCRX	Biocryst Pharmaceuticals Inc	Automatic Stock Option Grant	Award		$0	0.00	+40K	40K	5/25/2021	Direct

Previous1Next

Showing 1 to 18 of 18 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.